Ropivacaine Hydrochloride Injection
Product Images NDC 43066-023

Product Visual Gallery

This gallery contains 17 technical images submitted to the FDA as part of the official labeling for Ropivacaine Hydrochloride (NDC 43066-023). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Baxter Healthcare Corporation, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structural Formula (Image 01)

Chemical structure of ropivacaine hydrochloride, showing the molecular arrangement including a substituted aromatic ring and a piperidine ring with associated chemical groups.*

FDA Label Image

Representative Vial Label 43066-015-01 (Image 02)

Label for Ropivacaine Hydrochloride Injection, USP 0.2% (2 mg/mL) by Baxter Healthcare Corporation. The label specifies a 20 mL single dose vial with a total of 40 mg ropivacaine hydrochloride. The injection is indicated for infiltration, nerve block, and epidural administration only, with warnings that it is not for intravenous use. The label provides formulation details, storage instructions, and manufacturing information from Caplin Steriles Limited and Baxter Healthcare Corporation.*

FDA Label Image

Representative Carton Label 43066-015-10 Panel 1 Of 3 (Image 03)

Ropivacaine Hydrochloride Injection, USP 0.2% (40 mg per 20 mL, 2 mg/mL) vial carton label for infiltration, nerve block, and epidural administration. The package contains 10 single-dose vials of 20 mL each. Labeler is Baxter Healthcare Corporation. The label states Rx Only, sterile and preservative-free, with usage and storage instructions.*

FDA Label Image

Representative Carton Label 43066-015-10 Panel 2 Of 3 (Image 04)

Packaging label for Ropivacaine Hydrochloride Injection, USP 0.2% (2 mg/mL) marketed by Baxter Healthcare Corporation. The label indicates 40 mg/20 mL strength, intended for infiltration, nerve block, and epidural administration only. The package contains 10 single-dose 20 mL vials. Storage and manufacturing details are also included.*

FDA Label Image

Representative Carton Label 43066-015-10 Panel 3 Of 3 (Image 05)

FDA Label Image

Representative Container Label 43066-019-01 (Image 06)

Label for Ropivacaine Hydrochloride Injection, USP 0.5% (100 mg/20 mL) in a 20 mL single-dose vial. The label states it is for infiltration, nerve block, and epidural administration only and not for intravenous use. It contains details on the active ingredient amount per mL, manufacturer Baxter Healthcare Corporation, and storage instructions.*

FDA Label Image

Representative Carton Label 43066-019-10 Panel 1 Of 3 (Image 07)

Ropivacaine Hydrochloride Injection, USP 0.5% (5 mg/mL), 100 mg per 20 mL vial, labeled for infiltration, nerve block, and epidural administration only, not for intravenous use. The label states it is sterile, nonpyrogenic, preservative-free, and single-dose vial format. Manufactured by Baxter Healthcare Corporation. The NDC is 43066-019-10.*

FDA Label Image

Representative Carton Label 43066-019-10 Panel 2 Of 3 (Image 08)

Ropivacaine Hydrochloride Injection, USP 5 mg/mL (0.5%), in 20 mL single-dose vials. The label specifies use for infiltration, nerve block, and epidural administration only, not for intravenous administration. Manufactured by Caplin Steriles Limited and distributed by Baxter Healthcare Corporation. The packaging shows storage instructions and product identifiers including NDC 43066-019-10.*

FDA Label Image

Representative Carton Labeling 43066-019-10 Panel 3 Of 3 (Image 09)

FDA Label Image

Representative Container Label 43066-023-01 (Image 10)

Ropivacaine Hydrochloride Injection, USP 0.5% (5 mg/mL) in a 30 mL single-dose vial. The label indicates use for infiltration, nerve block, and epidural administration only, not for intravenous use. Manufactured by Caplin Steriles Limited and distributed by Baxter Healthcare Corporation. Sterile and preservative-free.*

FDA Label Image

Representative Carton Label 43066-023-10 Panel 1 Of 3 (Image 11)

Label for Ropivacaine Hydrochloride Injection, USP 0.5% (150 mg/30 mL or 5 mg/mL) single-dose vials. The label includes usage instructions for infiltration, nerve block, and epidural administration, specifying it is not for intravenous use. It also provides storage instructions, ingredient information, and cautions. The label is from Baxter Healthcare Corporation and indicates a package size of 10 vials of 30 mL each.*

FDA Label Image

Representative Carton Label 43066-023-10 Panel 2 Of 3 (Image 12)

Label for Ropivacaine Hydrochloride Injection, USP 0.5% (5 mg/mL) from Baxter Healthcare Corporation. The label specifies 150 mg per 30 mL vial (5 mg/mL), intended for infiltration, nerve block, and epidural administration only, not for intravenous use. The package contains 10 single-dose 30 mL vials. It is Rx only and includes manufacturer information from Caplin Steriles Limited, India, and distributor details for Baxter Healthcare, USA.*

FDA Label Image

Representative Carton Label 43066-023-10 Panel 3 Of 3 (Image 13)

FDA Label Image

Representative Container Label 43066-027-01 (Image 14)

Ropivacaine Hydrochloride Injection, USP 1% (200 mg/20 mL or 10 mg/mL) vial label. It is for epidural administration only and not for intravenous use. Manufactured by Caplin Steriles Limited and distributed by Baxter Healthcare Corporation, this single-dose vial contains 20 mL of preservative-free, sterile ropivacaine hydrochloride injection.*

FDA Label Image

Representative Carton Label 43066-027-10 Panel 1 Of 3 (Image 15)

Packaging label for Ropivacaine Hydrochloride Injection, USP 1% (10 mg/mL) by Baxter Healthcare Corporation. The carton contains 10 single-dose vials of 20 mL each, totaling 200 mg per package. It is labeled for epidural administration only and not for intravenous use, with additional drug concentration and preservative-free status noted.*

FDA Label Image

Representative Carton Label 43066-027-10 Panel 2 Of 3 (Image 16)

Ropivacaine Hydrochloride Injection, USP 1% (10 mg/mL) in 20 mL single dose vials, packaged as 10 vials per box. The label states 'For Epidural Administration Only. Not for Intravenous Administration.' Manufactured by Caplin Steriles Limited, India, and distributed by Baxter Healthcare Corporation, Deerfield, IL. Storage instructions indicate 20° to 25°C (68° to 77°F).*

FDA Label Image

Representative Carton Label 43066-027-10 Panel 3 Of 3 (Image 17)

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.